Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Assessment of illness acceptance by patients with COPD and the prevalence of depression and anxiety in COPD.

Uchmanowicz I, Jankowska-Polanska B, Motowidlo U, Uchmanowicz B, Chabowski M.

Int J Chron Obstruct Pulmon Dis. 2016 May 9;11:963-70. doi: 10.2147/COPD.S102754. eCollection 2016 May 9.

2.

Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study.

Hyun MK, Lee NR, Jang EJ, Yim JJ, Lee CH.

Int J Chron Obstruct Pulmon Dis. 2016 Apr 11;11:747-54. doi: 10.2147/COPD.S96969. eCollection 2016 Apr 11.

3.

Strategies to improve anxiety and depression in patients with COPD: a mental health perspective.

Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G, Tzanakis N.

Neuropsychiatr Dis Treat. 2016 Feb 9;12:297-328. doi: 10.2147/NDT.S79354. eCollection 2016 Feb 9. Review.

4.

Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).

Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S.

Blood. 2011 Oct 27;118(17):4723-31. doi: 10.1182/blood-2011-04-348730. Epub 2011 Aug 5.

5.

Impact of inflammatory bowel disease and high-dose steroid exposure on pupillary responses to negative information in pediatric depression.

Jones NP, Siegle GJ, Proud L, Silk JS, Hardy D, Keljo DJ, Dahl RE, Szigethy E.

Psychosom Med. 2011 Feb-Mar;73(2):151-7. doi: 10.1097/PSY.0b013e318207ffea. Epub 2011 Jan 7.

6.

General medical with depression drugs associated.

Rogers D, Pies R.

Psychiatry (Edgmont). 2008 Dec;5(12):28-41.

7.

Mood and Cognitive Changes During Systemic Corticosteroid Therapy.

Brown ES, Chandler PA.

Prim Care Companion J Clin Psychiatry. 2001 Feb;3(1):17-21.

Supplemental Content

Support Center